Last edition
News about
Aragen Commissions its New Formulations Manufacturing Facility in Hyderabad
This state-of-the-art facility, set up at an investment of USD 3Mn, is located at the Mallapur Campus in Hyderabad and spans over 12,000 square feet area.
Linde Starts Up New Air Separation Unit in Hyderabad
This plant will be producing in total 250 tonnes per day of gases including liquid medical oxygen, nitrogen and argon, catering to the requirements of healthcare, pharma and other industrial sectors of the region.
Shilpa Medicare Ltd, Unit IV, Jadcherla, Telangana Clears TGA, Australia GMP Inspection
The facility is involved in manufacturing, packaging, labelling, testing and release of finished dosage forms (sterile injections and non-sterile oral solids) for the treatment of various forms of cancer and adjuvant therapy.
The FDA has determined the inspection classification as 'OAI' (Official Action Indicated). The OAI status may cause delay and/or withholding of pending product approvals or supplements from the facility.
Dermatological diseases affect more than 900 million people worldwide. Significant advancements in the treatment of various skin conditions and disorders have been made.
Sun Pharma Recalls 144 Bottles of Anti-Depression Drug from US Market
Sun Pharmaceutical Industries Inc has recalled 144 bottles of a generic anti-depression medicine from the US market due to a manufacturing issue, according to the U.S. Food and Drug Administration (FDA).
eXmoor Opens GMP Facility in the UK
The 65,000 sq ft facility offers much-needed capacity and capability to help scale the next generation of CGTs for human trials and beyond.
C2 PHARMA Expands API Portfolio with Global Regulatory Access Ahead of CPhI Barcelona
C2 PHARMA is expanding its global access to its portfolio of active pharmaceutical ingredients (APIs) with new regulatory submissions and approvals.
Glenmark Pharmaceuticals Gets ANDA Approval for Apremilast Tablets, 10 mg, 20 mg and 30 mg
According to IQVIATM sales data for the 12-month period ending August 2023, the Otezla® Tablets, 10 mg, 20 mg, and 30 mg market2 achieved annual sales of approximately USD 3.7 billion.
Linde Starts Up New Air Separation Unit in Hyderabad
This plant will be producing in total 250 tonnes per day of gases including liquid medical oxygen, nitrogen and argon, catering to the requirements of healthcare, pharma and other industrial sectors of the region.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy